Johann von Felden (J von Felden)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 31

Top Venues

Cancers

Hepatology communications

Gut

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Lorenz Kocheise, Martin Schönlein, Berit Behrends, Vincent Joerg, Christian Casar, Thorben W Fruendt, Thomas Renné, Asmus Heumann, Jun Li, Samuel Huber, Ansgar Wilhelm Lohse, Klaus Pantel, Sabine Riethdorf, Henning Wege, Kornelius Schulze, Johann von Felden
EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma. Scientific reports 13 (1) (2023)
Vincent Joerg, Bernhard Scheiner, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Martin Schönlein, Lorenz Kocheise, Ansgar Wilhelm Lohse, Samuel Huber, Henning Wege, Ahmed Kaseb, Yinghong Wang, Antony Mathew, Andrew Kuang, Mahvish Muzaffar, Yehia I Abugabal, Shadi Chamseddine, Samuel Phen, Jaekyung Cheon, Pei-Chang Lee, Lorenz Balcar, Anja Krall, Celina Ang, Linda Wu, Anwaar Saeed, Yi-Hsiang Huang, Bertram Bengsch, Lorenza Rimassa, Arndt Weinmann, Rudolf Stauber, James Korolewicz, Matthias Pinter, Amit G Singal, Hong Jae Chon, David J Pinato, Kornelius Schulze, Johann von Felden
Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study. Hepatology communications 7 (11) (2023)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Anastasios D Giannou, Jöran Lücke, Dörte Kleinschmidt, Ahmad Mustafa Shiri, Babett Steglich, Mikolaj Nawrocki, Tao Zhang, Dimitra E Zazara, Jan Kempski, Lilan Zhao, Olympia Giannou, Theodora Agalioti, Leonie Brockmann, Franziska Bertram, Morsal Sabihi, Marius Böttcher, Florian Ewald, Kornelius Schulze, Johann von Felden, Andres Machicote, Ioannis C Maroulis, Petra Clara Arck, Julia-Kristin Grass, Baris Mercanoglu, Matthias Reeh, Stefan Wolter, Michael Tachezy, Hannes Seese, Myrto Theodorakopoulou, Panagis M Lykoudis, Asmus Heumann, Faik G Uzunoglu, Tarik Ghadban, Oliver Mann, Jakob R Izbicki, Jun Li, Anna Duprée, Nathaniel Melling, Nicola Gagliani, Samuel Huber
A Critical Role of the IL-22-IL-22 Binding Protein Axis in Hepatocellular Carcinoma. Cancers 14 (24) (2022)
Thorben W Fründt, Christian Casar, Johann von Felden, Ulrike Schöler, Maximilian Priebe, Jenny Kraczyk, Hannes Ahrend, Johannes Salamon, Gerhard Adam, Samuel Huber, Ansgar W Lohse, Henning Wege, Kornelius Schulze
Equal Efficacy and Safety Profile in Elderly Patients with Hepatocellular Carcinoma Receiving Palliative Treatment. Cancers 14 (3) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Anastasios D Giannou, Jöran Lücke, Dörte Kleinschmidt, Ahmad Mustafa Shiri, Babett Steglich, Mikolaj Nawrocki, Tao Zhang, Dimitra E Zazara, Jan Kempski, Lilan Zhao, Olympia Giannou, Theodora Agalioti, Leonie Brockmann, Franziska Bertram, Morsal Sabihi, Marius Böttcher, Florian Ewald, Kornelius Schulze, Johann von Felden, Andres Machicote, Ioannis C Maroulis, Petra Clara Arck, Julia-Kristin Grass, Baris Mercanoglu, Matthias Reeh, Stefan Wolter, Michael Tachezy, Hannes Seese, Myrto Theodorakopoulou, Panagis M Lykoudis, Asmus Heumann, Faik G Uzunoglu, Tarik Ghadban, Oliver Mann, Jakob R Izbicki, Jun Li, Anna Duprée, Nathaniel Melling, Nicola Gagliani, Samuel Huber
A Critical Role of the IL-22-IL-22 Binding Protein Axis in Hepatocellular Carcinoma. Cancers 14 (24) (2022)
Stephan Buch, Hamish Innes, Philipp Ludwig Lutz, Hans Dieter Nischalke, Jens U Marquardt, Janett Fischer, Karl Heinz Weiss, Jonas Rosendahl, Astrid Marot, Marcin Krawczyk, Markus Casper, Frank Lammert, Florian Eyer, Arndt Vogel, Silke Marhenke, Johann von Felden, Rohini Sharma, Stephen Rahul Atkinson, Andrew McQuillin, Jacob Nattermann, Clemens Schafmayer, Andre Franke, Christian P Strassburg, Marcella Rietschel, Heidi Altmann, Stefan Sulk, Veera Raghavan Thangapandi, Mario Brosch, Carolin Lackner, Rudolf E Stauber, Peter Lemmer, Alexander Link, Thomas Reiberger, Mattias Mandorfer, Georg Semmler, Bernhard Scheiner, Christian Datz, Stefano Romeo, Stefano Ginanni Corradini, William Lucien Irving, Joanne R Morling, Indra Neil Guha, Eleanor Barnes, M Azim Ansari, Jocelyn Quistrebert, Luca Vittorio Valenti, Sascha A Müller, Marsha Yvonne Morgan, Jean-François Dufour, Jonel Trebicka, Thomas Berg, Pierre Deltenre, Sebastian Mueller, Jochen Hampe, Felix Stickel
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study. Gut (2022)
Yue Linda Wu, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Jaekyung Cheon, Naoshi Nishida, Anwaar Saeed, Brooke Wietharn, Antonella Cammarota, Tiziana Pressiani, Nicola Personeni, Matthias Pinter, Bernhard Scheiner, Lorenz Balcar, Yi-Hsiang Huang, Samuel Phen, Abdul Rafeh Naqash, Caterina Vivaldi, Francesca Salani, Gianluca Masi, Dominic Bettinger, Arndt Vogel, Martin Schönlein, Johann von Felden, Kornelius Schulze, Henning Wege, Peter Robert Galle, Masatoshi Kudo, Lorenza Rimassa, Amit G Singal, Rohini Sharma, Alessio Cortellini, Vincent E Gaillard, Hong Jae Chon, David James Pinato, Celina Ang
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab. Cancers 14 (23) (2022)
Amanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta, Carlos Villacorta-Martin, Edgar G Kozlova, Sebastiao N Martins-Filho, Johann von Felden, Mehmet Eren Ahsen, Erin Bresnahan, Gabriela Hernandez-Meza, Ismail Labgaa, Delia D'Avola, Myron E Schwartz, Josep M Llovet, Daniela Sia, Swan Thung, Bojan Losic, Amaia Lujambio, Augusto Villanueva
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinoma. PLoS genetics 17 (6) (2021)
Ismail Labgaa, Johann von Felden, Amanda J Craig, Sebastiao N Martins-Filho, Carlos Villacorta-Martin, Nicolas Demartines, Olivier Dormond, Delia D'Avola, Augusto Villanueva
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone-Dependent Release of Circulating Tumor DNA. Hepatology communications 5 (6) (2021)
Johann von Felden, Augusto Villanueva
Role of Molecular Biomarkers in Liver Transplantation for Hepatocellular Carcinoma. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 26 (6) (2021)
Hamish Innes, Hans Dieter Nischalke, Indra Neil Guha, Karl Heinz Weiss, Will Irving, Daniel Gotthardt, Eleanor Barnes, Janett Fischer, M Azim Ansari, Jonas Rosendahl, Shang-Kuan Lin, Astrid Marot, Vincent Pedergnana, Markus Casper, Jennifer Benselin, Frank Lammert, John McLauchlan, Philip L Lutz, Victoria Hamill, Sebastian Mueller, Joanne R Morling, Georg Semmler, Florian Eyer, Johann von Felden, Alexander Link, Arndt Vogel, Jens-Uwe Marquardt, Stefan Sulk, Jonel Trebicka, Luca Vittorio Valenti, Christian Datz, Thomas Reiberger, Clemens Schafmayer, Thomas Berg, Pierre Deltenre, Jochen Hampe, Felix Stickel, Stephan Buch
The rs429358 Locus in Apolipoprotein E Is Associated With Hepatocellular Carcinoma in Patients With Cirrhosis. Hepatology communications 6 (5) (2021)
Johann von Felden, Teresa Garcia-Lezana, Navneet Dogra, Edgar Gonzalez-Kozlova, Mehmet Eren Ahsen, Amanda Craig, Stacey Gifford, Benjamin Wunsch, Joshua T Smith, Sungcheol Kim, Jennifer E L Diaz, Xintong Chen, Ismail Labgaa, Philipp Haber, Reena Olsen, Dan Han, Paula Restrepo, Delia D'Avola, Gabriela Hernandez-Meza, Kimaada Allette, Robert Sebra, Behnam Saberi, Parissa Tabrizian, Amon Asgharpour, Douglas Dieterich, Josep M Llovet, Carlos Cordon-Cardo, Ash Tewari, Myron Schwartz, Gustavo Stolovitzky, Bojan Losic, Augusto Villanueva
Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer. Gut (2021)
Thorben Fründt, Linda Krause, Elaine Hussey, Bettina Steinbach, Daniel Köhler, Johann von Felden, Kornelius Schulze, Ansgar W Lohse, Henning Wege, Heidi Schwarzenbach
Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients. Cancers 13 (10) (2021)
Gabriela Hernandez-Meza, Johann von Felden, Edgar E Gonzalez-Kozlova, Teresa Garcia-Lezana, Judit Peix, Anna Portela, Amanda J Craig, Sergi Sayols, Myron Schwartz, Bojan Losic, Vincenzo Mazzaferro, Manel Esteller, Josep M Llovet, Augusto Villanueva
DNA Methylation Profiling of Human Hepatocarcinogenesis. Hepatology (Baltimore, Md.) 74 (1) (2021)
Felix Piecha, Jan-Michael Gänßler, Ann-Kathrin Ozga, Malte H Wehmeyer, Julia Dietz, Johannes Kluwe, Alena Laschtowitz, Johann von Felden, Martina Sterneck, Sabine Jordan, Sven Pischke, Ansgar W Lohse, Julian Schulze Zur Wiesch
Treatment and re-treatment results of HCV patients in the DAA era. PloS one 15 (5) (2020)
Johann von Felden, Teresa Garcia-Lezana, Kornelius Schulze, Bojan Losic, Augusto Villanueva
Liquid biopsy in the clinical management of hepatocellular carcinoma. Gut 69 (11) (2020)
Bojan Losic, Amanda J Craig, Carlos Villacorta-Martin, Sebastiao N Martins-Filho, Nicholas Akers, Xintong Chen, Mehmet Eren Ahsen, Johann von Felden, Ismail Labgaa, Delia DʹAvola, Kimaada Allette, Sergio A Lira, Glaucia C Furtado, Teresa Garcia-Lezana, Paula Restrepo, Ashley Stueck, Stephen C Ward, Maria I Fiel, Spiros P Hiotis, Ganesh Gunasekaran, Daniela Sia, Eric E Schadt, Robert Sebra, Myron E Schwartz, Josep M Llovet, Swan Thung, Gustavo Stolovitzky, Augusto Villanueva
Intratumoral heterogeneity and clonal evolution in liver cancer. Nature communications 11 (1) (2020)
Johann von Felden, Henning Wege, Kornelius Schulze
Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma. Hepatology communications 4 (9) (2020)
Johann von Felden, Amanda J Craig, Teresa Garcia-Lezana, Ismail Labgaa, Philipp K Haber, Delia D'Avola, Amon Asgharpour, Douglas Dieterich, Antoinette Bonaccorso, Miguel Torres-Martin, Daniela Sia, Max W Sung, Parissa Tabrizian, Myron E Schwartz, Josep M Llovet, Augusto Villanueva
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. Oncogene 40 (1) (2020)
Sven Pischke, Jean-Marie Peron, Moritz von Wulffen, Johann von Felden, Christoph Höner Zu Siederdissen, Sophie Fournier, Marc Lütgehetmann, Christoph Iking-Konert, Dominik Bettinger, Gabriella Par, Robert Thimme, Alain Cantagrel, Ansgar W Lohse, Heiner Wedemeyer, Robert de Man, Vincent Mallet
Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study. Viruses 11 (2) (2019)
Amanda J Craig, Johann von Felden, Teresa Garcia-Lezana, Samantha Sarcognato, Augusto Villanueva
Tumour evolution in hepatocellular carcinoma. Nature reviews. Gastroenterology & hepatology 17 (3) (2019)
Bernhard Scheiner, Martha M Kirstein, Florian Hucke, Fabian Finkelmeier, Kornelius Schulze, Johann von Felden, Sandra Koch, Philipp Schwabl, Jan B Hinrichs, Fredrik Waneck, Oliver Waidmann, Thomas Reiberger, Christian Müller, Wolfgang Sieghart, Michael Trauner, Arndt Weinmann, Henning Wege, Jörg Trojan, Markus Peck-Radosavljevic, Arndt Vogel, Matthias Pinter
Programmed cell death protein-1 (PD-1)-targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicentre real-world cohort. Alimentary pharmacology & therapeutics 49 (10) (2019)
Marina Ruiz de Galarreta, Erin Bresnahan, Pedro Molina-Sánchez, Katherine E Lindblad, Barbara Maier, Daniela Sia, Marc Puigvehí, Verónica Miguela, María Casanova-Acebes, Maxime Dhainaut, Carlos Villacorta-Martin, Aatur D Singhi, Akshata Moghe, Johann von Felden, Lauren Tal Grinspan, Shuang Wang, Alice Oliffson Kamphorst, Satdarshan P Monga, Brian D Brown, Augusto Villanueva, Josep M Llovet, Miriam Merad, Amaia Lujambio
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma. Cancer discovery 9 (8) (2019)
Johann von Felden, Johannes Vermehren, J Schulze Zur Wiesch, C Sarrazin, S Christensen
Editorial: genotype 3 HCV-who still needs ribavirin in a pan-genotypic era? Authors' reply. Alimentary pharmacology & therapeutics 47 (11) (2019)
Delia D'Avola, Carlos Villacorta-Martin, Sebastiao N Martins-Filho, Amanda Craig, Ismail Labgaa, Johann von Felden, Allette Kimaada, Antoinette Bonaccorso, Parissa Tabrizian, Boris M Hartmann, Robert Sebra, Myron Schwartz, Augusto Villanueva
High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma. Scientific reports 8 (1) (2018)
Ismail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, Amanda J Craig, Johann von Felden, Sebastiao N Martins-Filho, Daniela Sia, Ashley Stueck, Stephen C Ward, M Isabel Fiel, Milind Mahajan, Parissa Tabrizian, Swan N Thung, Celina Ang, Scott L Friedman, Josep M Llovet, Myron Schwartz, Augusto Villanueva
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma. Oncogene 37 (27) (2018)
Johann von Felden, Johannes Vermehren, P Ingiliz, S Mauss, T Lutz, K G Simon, H W Busch, A Baumgarten, K Schewe, D Hueppe, C Boesecke, J K Rockstroh, M Daeumer, N Luebke, J Timm, J Schulze Zur Wiesch, C Sarrazin, S Christensen
High efficacy of sofosbuvir/velpatasvir and impact of baseline resistance-associated substitutions in hepatitis C genotype 3 infection. Alimentary pharmacology & therapeutics 47 (9) (2018)
Johann von Felden, C Scheurich, J Yamamura, D M Brainard, E Mogalian, A W Lohse, J Schulze Zur Wiesch
Successful treatment of chronic hepatitis C with ground ledipasvir/sofosbuvir in a patient with Crohn's disease and short bowel syndrome. Journal of viral hepatitis 25 (2) (2017)

Johann von Felden.css-eqlu8i{font-size:small;padding-left:4px;} (J von Felden)

Publication Activity (10 Years)

Top Topics

Top Venues

Johann von Felden (J von Felden)